Skip to main content
Clinical Trials/IRCT20221026056309N1
IRCT20221026056309N1
Not yet recruiting
Phase 3

15-Investigating the safety and effectiveness of the injection of conditioned medium derived from keratinocyte and fibroblast cells forascin compared to platelet rich plasma in the treatment of androgenic alopecia: a blinded randomized controlled interventional study

Iran University of Medical Sciences0 sites24 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Iran University of Medical Sciences
Enrollment
24
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Men and women with hereditary hormonal hair loss
  • Hamilton score 2\-5 in men and Ludwig score 1\-3 in women
  • Complete consent of the patient to participate in the plan

Exclusion Criteria

  • Platelet disorders or thrombocytopenia
  • Patients receiving anticoagulants
  • Receiving any topical or systemic medication in the last 3 months for hair loss

Outcomes

Primary Outcomes

Not specified

Similar Trials